Adalimumab weekly vs placebo
Proportion of participants with infectious adverse effects · participants with hidradenitis suppurativa
Adalimumab weekly showed no clear difference in proportion of participants with infectious adverse effects compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.94 [0.55, 1.62]1 study · 102 participantsModerate